ALKERMES | ALKS - 股本和储备

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 4.4B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	股本和储备	更改		日
AbbVie	USD -3.27B		628M	2025-12
Acadia Pharmaceuticals	USD 917.27M		94.89M	2025-09
ALKERMES	USD 1.82B		85.86M	2025-12
Amgen	USD 8.66B		961M	2025-12
Biogen	USD 18.21B		573.5M	2025-09
BioMarin Pharmaceutical	USD 6.09B		30.29M	2025-12
Bristol-Myers Squibb	USD 18.55B		1.06B	2025-09
Coherus Biosciences	USD 61.01M		26.76M	2025-12
Eli Lilly	USD 26.54B		2.74B	2025-12
Gilead Sciences	USD 22.62B		1.16B	2025-12
Heron Therapeutics	USD 13.28M		1.6M	2025-12
Ionis Pharmaceuticals	USD 617.97M		13.76M	2025-09
J&J	USD 78.47B		0	2025-09
Malin Corporation	EUR 193.2M		75M	2024-12
Merck	USD 51.85B		2.79B	2025-09
Minerva Neurosciences	USD -140.75M		106.17M	2025-12
Nektar Therapeutics	USD 85.09M		109.3M	2025-09
Neurocrine Biosciences	USD 3.25B		249.5M	2025-12
Otsuka Holdings	JPY 3.03T		174.32B	2025-12
Ovoca Bio	EUR 8.67M		4.76M	2022-06
Pfizer	USD 92.8B		4.11B	2025-09
Regeneron Pharmaceuticals	USD 31.26B		299.1M	2025-12
Vertex Pharmaceuticals	USD 18.67B		1.35B	2025-12